Levy, D; Celestino, Andréa Turbuck; Debes, A; Huachaca, Nélida; Schreier, Shirley 
; Maranhão, Raul Cavalcante ; Bydlowski, Sérgio Paulo
Fonte: Clinics. Nome do evento: Symposium Advances in Medical Research. Unidades: IQ, FCF, FM
Assuntos: GLICOPROTEÍNAS, SARCOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEVY, D et al. 3'-Cholesteryl-oligonucleotide/lipid nanoemulsion complex binds to LDL receptors and inhibits p-glycoprotein expression in a sarcoma cell line. Clinics. São Paulo: Instituto de Química, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2007APA
Levy, D., Celestino, A. T., Debes, A., Huachaca, N., Schreier, S., Maranhão, R. C., & Bydlowski, S. P. (2007). 3'-Cholesteryl-oligonucleotide/lipid nanoemulsion complex binds to LDL receptors and inhibits p-glycoprotein expression in a sarcoma cell line. Clinics. São Paulo: Instituto de Química, Universidade de São Paulo.NLM
Levy D, Celestino AT, Debes A, Huachaca N, Schreier S, Maranhão RC, Bydlowski SP. 3'-Cholesteryl-oligonucleotide/lipid nanoemulsion complex binds to LDL receptors and inhibits p-glycoprotein expression in a sarcoma cell line. Clinics. 2007 ; 62 S26 res. 052.[citado 2024 nov. 18 ]Vancouver
Levy D, Celestino AT, Debes A, Huachaca N, Schreier S, Maranhão RC, Bydlowski SP. 3'-Cholesteryl-oligonucleotide/lipid nanoemulsion complex binds to LDL receptors and inhibits p-glycoprotein expression in a sarcoma cell line. Clinics. 2007 ; 62 S26 res. 052.[citado 2024 nov. 18 ]
